Cutting-edge biotechnology driving the revolution in biologicals and redefining sustainable agriculture
Aphea.Bio is a leading player in the development of the next-generation of agricultural biological products based on naturally occurring microorganisms.
Aphea.Bio focuses on microbial strains that improve plant nutrient uptake (biostimulants) and protect crops against disease (biocontrol). Their mission is to reduce fertilizer and pesticide use while providing innovative and sustainable solutions for agriculture, especially large acre crops like maize and wheat.
Aphea.Bio is a Certified B Corporation, reflecting the commitment to meet high social and environmental impact, accountability and transparency.
At Aphea.Bio, we are harnessing the power of nature to help farmers grow more with less, improving yields while reducing chemical inputs. Achieving that balance demands investors who not only believe in the bioeconomy, but deeply understand its scientific and market realities. ECBF stands out as a true specialist partner: rigorous in their science-driven approach, proactive in their strategic support, and fully committed to measurable impact. Together, we're proving that innovation in agriculture can restore ecosystems while delivering growth.
Isabel Vercauteren
CEO
